Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 November, 2017 20:38 IST
Dr Reddy's to get up to USD 32.5 mn milestone payments for DFD-06
Source: IRIS | 22 Aug, 2017, 10.33AM
Comments  |  Post Comment
 

Dr. Reddy's Laboratories, through its wholly owned subsidiary Promius Pharma, LLC, announced today that it has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc. The drug is intended to be used for treatment of moderate to severe plaque psoriasis.

Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States. Promius Pharma is eligible to receive certain pre- and post-commercialization milestone payments of up to USD 32.5 million, followed by fixed royalty payments on net sales.

'We believe Encore and its management team are well positioned to realize the full potential of this asset DFD-06. We look forward to obtaining NDA approval this fall, enabling Encore's management team to quickly deliver this product to the providers and their patients." says Anil Namboodiripad, Ph.D., Senior Vice President, Proprietary Products, and President, Promius Pharma.

Shares of the company gained Rs 21.85, or 1.13%, to trade at Rs 1,955.00. The total volume of shares traded was 15,230 at the BSE (10.22 a.m., Tuesday).

   

Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Indian Hume Pipe secures order worth Rs 1.19 bn - 24-Nov-2017 15:14
Arshiya signs definitive agreements with Ascendas - 24-Nov-2017 11:20
IMP Powers commissions 20 KW hydro-kinetic project - 24-Nov-2017 10:38
Reliance concludes sale of certain assets operated by Carrizo Oil & Gas - 24-Nov-2017 10:25
Zydus Cadila gets USFDA nod for Minocycline HCl ER tablets - 24-Nov-2017 10:22
Zydus Cadila gets tentative approval for Tadalafil tablets - 24-Nov-2017 10:19
CG Power bags order worth Rs 1.11 bn from Indian Railways - 24-Nov-2017 10:09
Welspun Corp bags order for supply of 392K MTs pipes - 24-Nov-2017 10:04
Thomas Cook to sell 5.42% stake in Quess Corp via OFS - 23-Nov-2017 10:28
Tata Tele subscribers commence transitioning to Airtel network - 23-Nov-2017 10:13
Glenmark Pharma gets nod for generic Loestrin Fe 1/20 tablets - 22-Nov-2017 11:27
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer